These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 22271681)
1. The enhanced pre- and postnatal study for nonhuman primates: update and perspectives. Weinbauer GF; Fuchs A; Niehaus M; Luetjens CM Birth Defects Res C Embryo Today; 2011 Dec; 93(4):324-33. PubMed ID: 22271681 [TBL] [Abstract][Full Text] [Related]
2. The enhanced pre- and postnatal development study for monoclonal antibodies. Weinbauer GF; Luft J; Fuchs A Methods Mol Biol; 2013; 947():185-200. PubMed ID: 23138905 [TBL] [Abstract][Full Text] [Related]
3. Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option. Stewart J Reprod Toxicol; 2009 Sep; 28(2):220-5. PubMed ID: 19379807 [TBL] [Abstract][Full Text] [Related]
4. Object discrimination reversal as a method to assess cognitive impairment in nonhuman primate enhanced pre- and postnatal developmental (ePPND) studies: statistical power analysis. Cappon GD; Bowman CJ; Hurtt ME; Grantham LE Birth Defects Res B Dev Reprod Toxicol; 2012 Oct; 95(5):354-62. PubMed ID: 22930561 [TBL] [Abstract][Full Text] [Related]
5. Group size experiences with enhanced pre- and postnatal development studies in the long-tailed macaque ( Luetjens CM; Fuchs A; Baker A; Weinbauer GF Primate Biol; 2020; 7(1):1-4. PubMed ID: 32232119 [TBL] [Abstract][Full Text] [Related]
7. The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates, and group size considerations. Jarvis P; Srivastav S; Vogelwedde E; Stewart J; Mitchard T; Weinbauer GF Birth Defects Res B Dev Reprod Toxicol; 2010 Jun; 89(3):175-87. PubMed ID: 20544806 [TBL] [Abstract][Full Text] [Related]
8. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals. Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138 [TBL] [Abstract][Full Text] [Related]
9. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation. Martin PL; Sachs C; Imai N; Tsusaki H; Oneda S; Jiao Q; Treacy G Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):351-63. PubMed ID: 20540088 [TBL] [Abstract][Full Text] [Related]